Literature DB >> 24674698

Prognostic factors and survival in primary adult high grade brainstem astrocytoma: a population based study from 1973-2008.

Mahua Dey1, Yimo Lin2, Stephanie Melkonian3, Sandi Lam4.   

Abstract

Adult brainstem astrocytomas are a rare and heterogeneous group of malignancies. Most reports represent low-grade gliomas. This study used the Surveillance, Epidemiology and End Results (SEER) database to analyze the association between survival and demographic factors, tumor histology, and treatment characteristics among adult patients with high-grade brainstem astrocytoma (HGBSA). Adult patients with histologically confirmed diagnoses of primary HGBSA were studied. In univariate and multivariate analysis, we investigated the effect of demographics, tumor histology and treatment modality on survival. Overall median survival in the cohort of 240 adult patients was 7months, with 1, 2, 5 and 10year survival rates of 33.2%, 19.7%, 10.1%, and 8.3%, respectively. Age >50years (hazard ratio [HR] 1.98, 95% confidence interval [CI] 1.45-2.70, p<0.001) and grade IV versus grade III tumor (HR 1.61, 95% CI 1.15-2.26, p=0.006) were associated with statistically significant increased mortality in multivariate analyses. Surgical intervention trended toward association with lower mortality (HR 0.68, 95% CI 0.47-1.01, p=0.055). Our findings suggest that in patients with HGBSA, younger age and lower-grade histology are associated with better prognosis. Surgical intervention trended towards a significant association with better outcome, while radiation treatment was not associated with a statistically significant benefit in survival.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brainstem astrocytoma; Brainstem glioma; Brainstem tumor; Malignant glioma; SEER

Mesh:

Year:  2014        PMID: 24674698     DOI: 10.1016/j.jocn.2013.12.011

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  10 in total

1.  Differential and kinetic effects of cell cycle inhibitors on neoplastic and primary astrocytes.

Authors:  Veetai Li; Thomas J Langan; Kyla R Rodgers; Richard C Chou
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

2.  Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: A population-based analysis.

Authors:  Yun Sun; Zhi-Yong Xiong; Peng-Fei Yan; Liang-Lei Jiang; Chuan-Sheng Nie; Xuan Wang
Journal:  Bosn J Basic Med Sci       Date:  2019-11-08       Impact factor: 3.363

Review 3.  Patients' Survival with Astrocytoma After Treatment: a Systematic Review and Meta-analysis of Clinical Trial Studies.

Authors:  Nader Salari; Reza Fatahian; Mohsen Kazeminia; Amin Hosseinian-Far; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Indian J Surg Oncol       Date:  2022-04-25

4.  Association between extent of resection on survival in adult brainstem high-grade glioma patients.

Authors:  Joshua Doyle; Adham M Khalafallah; Wuyang Yang; Yi Sun; Chetan Bettegowda; Debraj Mukherjee
Journal:  J Neurooncol       Date:  2019-10-16       Impact factor: 4.130

5.  Outcomes of presumed malignant glioma treated without pathological confirmation: a retrospective, single-center analysis.

Authors:  Seth Andrew Climans; Ronald Cepe Ramos; Normand Laperriere; Mark Bernstein; Warren P Mason
Journal:  Neurooncol Pract       Date:  2020-03-16

6.  High-Grade Glioma of the Ventrolateral Medulla in an Adult: Case Presentation and Discussion of Surgical Considerations.

Authors:  Angela Spurgeon; Viet Le; Sanjay Konakondla; Douglas C Miller; Tamera Hopkins; N Scott Litofsky
Journal:  Case Rep Neurol Med       Date:  2016-05-08

7.  Treatment of adult brainstem glioma with combined antiangiogenic therapy: a case report and literature review.

Authors:  Dongdong Yu; Guang Han; Huali Liu; Likun Gao; Vivek Verma
Journal:  Onco Targets Ther       Date:  2019-02-18       Impact factor: 4.147

8.  Prognosis of Patients With Brainstem Glioblastoma Based on "age, surgery and radiotherapy": A SEER Database Analysis.

Authors:  Yitong Li; Narasimha M Beeraka; Wenchang Guo; Yuying Lei; Qilu Hu; Litao Guo; Ruitai Fan; Junqi Liu; Aixia Sui
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

9.  H3K27M Mutation Doesn't Mean Worse Prognosis in Old Patients.

Authors:  Xiao Mu Hu; Xiao Yu Nie; Kai Lun Xu; Yin Wang; Feng Tang; Zun Guo Du; Ji Xiong
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

10.  Development and Validation of a Personalized Prognostic Prediction Model for Patients With Spinal Cord Astrocytoma.

Authors:  Sheng Yang; Xun Yang; Huiwen Wang; Yuelin Gu; Jingjing Feng; Xianfeng Qin; Chaobo Feng; Yufeng Li; Lijun Liu; Guoxin Fan; Xiang Liao; Shisheng He
Journal:  Front Med (Lausanne)       Date:  2022-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.